Clinical Trials · NCT07554638

Incretin Therapies in Obesity-related HFpEF

Name: Incretin Therapies in Obesity-related HFpEF
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

RecruitingPhase 4Tirzepatide

Phase: Phase 4
Recruitment status: Recruiting
Sponsor: Columbia University
Enrollment: 50
Start date: Aug 2026
Locations: 1 site, United States
Primary endpoint: Plasma volume

View Tirzepatide compound reference